DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/v6jqmg/admetoxicology) has announced the addition of the "ADME-Toxicology Testing - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2018. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for ADME-Toxicology Testing in US$ Million by the following Product Segments:
- Toxicology Testing (In-Vivo, & In-Vitro)
- ADME Testing.
Company profiles are primarily based on public domain information including company URLs. The report profiles 75 companies including many key and niche players such as:
- Accelrys, Inc.
- ACEA Biosciences, Inc.
- ADMEcell, Inc.
- Agilent Technologies, Inc.
- Albany Molecular Research, Inc.
- Bayer Technology Services GmbH
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying.
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
II. EXECUTIVE SUMMARY
2. INDUSTRY OVERVIEW
3. MARKET DYNAMICS
4. DRUG DISCOVERY & DEVELOPMENT
5. PRODUCT OVERVIEW
6. PRODUCT INNOVATIONS/INTRODUCTIONS
7. RECENT INDUSTRY ACTIVITY
8. FOCUS ON SELECT PLAYERS
9. GLOBAL MARKET PERSPECTIVE
1. THE UNITED STATES
6. REST OF WORLD
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 75 (including Divisions/Subsidiaries - 80)
- The United States (49)
- Canada (2)
- Japan (1)
- Europe (26)
- France (3)
- Germany (3)
- The United Kingdom (10)
- Spain (2)
- Rest of Europe (8)
- Asia-Pacific (Excluding Japan) (2)
For more information visit http://www.researchandmarkets.com/research/v6jqmg/admetoxicology